Carisma Therapeutics Inc. Current Liabilities
Carisma Therapeutics Inc. had Current Liabilities of $6.81 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-11-12
- 2025-09-30: Liabilities, Current $6.81M.
- 2025-06-30: Liabilities, Current $8.95M.
- 2025-03-31: Liabilities, Current $10.45M.
- 2024-12-31: Liabilities, Current $16.05M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $6.81M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $8.95M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $10.45M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $16.05M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $10.56M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $15.62M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $13.14M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $15.91M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $12.95M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $17.97M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $21.48M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $19.67M 10-K · filed 2024-04-01 | $30.98M 10-K · filed 2023-02-28 |
| 2022-09-30 | $34.70M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $32.01M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | $8.47M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $11.57M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $12.59M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $18.83M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $17.37M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $18.05M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $9.71M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $6.51M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $7.37M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $8.52M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $9.09M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.95M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $7.05M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $6.11M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $6.56M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $4.53M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.25M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $4.72M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $4.40M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $3.85M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.23M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $3.98M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $6.26M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.01M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $2.28M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $7.58M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $7.61M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $5.47M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $4.64M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $5.20M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $6.51M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $6.03M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $6.30M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $5.35M 10-K · filed 2015-03-06 |